Obermatt

Ambu

CPH:AMBU B · DK0060946788
Health Care Equipment & SuppliesMedium

360

77
EV / EBIT27
Price / Owner Earnings19
Owner Earnings Yield61
Dividend Yield37
Price/Sales34
EV / Gross Profit41
Price/Book40
Return on Capital67
Cash Return on Capital72
Return on Equity61
EBIT Margin56
Gross Profitability74
Cash Conversion49
Accruals34
Owner Earnings Margin70
Sales growth70
Profit Growth51
Long-Term EPS Growth98
Owner Earnings Growth63
Reinvestment86
Price momentum11
Debt load81
Refinancing72
Debt Payback100
Liquidity82
Analyst ratings37
Opinion Changes65
Price Target Upside68
Market mood11
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Ambu clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeMedium
TypePublic Company
ExchangeCPSE
Founded1956
Employees1,294
Websiteambu.com
ISINDK0060946788
Last UpdateApr 2, 2026
Index & Theme
CardiovascularPulmonologyRespiratoryBiomedical EngineeringNeurologyEar Nose & Throat (ENT)Health DiagnosticsUrologyHealth CareMedical Device

Description

Ambu A/S is a global medical device company specializing in the development, manufacturing, and marketing of innovative healthcare solutions, primarily focusing on anesthesia, patient monitoring, and airway management. The company aims to meet the n…

Analysis

Middle-of-the-road

Ambu A/S sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is expensive. The owner-earnings multiple stands at 35.1×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 14% a year, against analyst forecasts of 35%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is sturdy. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
55
2023202420252026

All-time high

92

Jan 2025

All-time low

1

Jan 2023

Average rank

58

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
34
9
10
12
Price/Earnings
9
5
5
1
Price/Book
40
12
19
11
Dividend Yield
37
39
30
30
Value (overall)
21
5
5
5

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Ambu with its peers
IVF Hartmann
SWX:VBSN
68
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Medtronic
NYQ:MDT
70
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Siemens Healthineers
GER:SHL
17
CountryGermany
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Spire
LSE:SPI
38
CountryUK
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Cosmo Pharmaceuticals
SWX:COPN
47
CountryIreland
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Demant
CPH:DEMANT
25
CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →